Pfizer drops after report on U.S. probe related to its COVID vaccine success

Alexandros Michailidis/iStock Editorial via Getty Images Pfizer ( NYSE: PFE ) shares reached a session low on Wednesday after The Wall Street Journal reported that the U.S. attorney’s office in Manhattan has started an investigation into whether the New York-based pharma giant deliberately delayed announcing the success of its.